Faisal Zain stands at the intersection of clinical innovation and financial vigilance, bringing years of expertise from the highly regulated world of medical device manufacturing into the complex arena of healthcare payment integrity. As a leader who has seen firsthand how technology can both advance patient care and be exploited by sophisticated bad actors, Zain offers a unique perspective on protecting the healthcare ecosystem. His approach transcends simple “pay and chase” tactics, focusing instead on how data-driven governance and cross-industry collaboration can safeguard billions of dollars in healthcare resources. In this discussion, we explore the shifting landscape of fraud, waste, and abuse, the necessity of proactive prevention strategies, and how the integration of advanced analytics is changing the way health plans maintain affordability and trust in 2026.
With federal reports projecting billions in potential recoveries, how are advancements in artificial intelligence and modern technology reshaping the battle against fraud, waste, and abuse?
The landscape has become incredibly sophisticated because technology is a double-edged sword that both sides are wielding with increasing intensity. When we look back at the $7.13 billion in expected recoveries and receivables reported by the HHS OIG in 2024, we see the sheer scale of the challenge we are still managing today in 2026. Bad actors are now using artificial intelligence to generate incredibly convincing but entirely fraudulent clinical documentation, which allows them to accelerate questionable billing patterns at a speed that traditional manual reviews simply cannot catch. This has created a surge in “phantom provider” activity and complex schemes in areas like telehealth and specialty drugs, where the physical paper trail is often thin. We are countering this by using that same technology to detect these anomalies in real-time, identifying the subtle “digital fingerprints” of automated billing before the money ever leaves the plan’s accounts. It feels like a high-stakes chess match where the goal is to use data-driven coordination to protect the integrity of every dollar intended for patient care.
Moving from a reactive “pay and chase” model to a proactive prevention strategy is often easier said than done; what specific internal shifts must occur to make this transition successful?
Shifting to a prepay strategy is a fundamental change in philosophy that requires us to look at the entire lifecycle of a claim rather than just the tail end. We have to move away from the exhaustion of trying to recover funds after they’ve been disbursed, which is not only costly and burdensome but often results in significant provider abrasion. An intentional prevention strategy means we are looking at everything from system accuracy and provider contracts to the clinical appropriateness of the services being billed. It requires a complete view of the process, ensuring that we have clear criteria for when a provider should be placed on a prepayment review versus when a simple operational edit might suffice. When we prioritize these actions, we have to balance exposure rates and velocity with the potential impact on the member’s experience, ensuring that our quest for integrity doesn’t inadvertently create barriers to necessary care. It is about being strategic rather than just being fast, using reactive analytics to inform our proactive edits so that the same mistake never happens twice.
Could you share an example of how breaking down silos between claims operations and special investigative units can lead to more sustainable outcomes for health plans?
The most successful programs I have seen are those where the vision for payment integrity is unified across the entire organization, regardless of the reporting structure. I remember a specific case with a Blue Plan client where the payment integrity team noticed a recurring pattern of inappropriate modifier use that seemed a bit too consistent to be accidental. Instead of just flagging it for a future audit, the case was moved directly to the Special Investigative Unit (SIU), where they were able to act on six open cases simultaneously, all of which resulted in successful recoveries. But the real victory wasn’t just getting the money back; it was the follow-through, where the operations team added a permanent edit to prevent that specific modifier misuse from happening again while also launching mandatory provider education. This coordinated loop—detecting, recovering, educating, and then hard-coding the prevention—is what creates a sustainable program. It transforms a departmental task into an enterprise capability, where everyone from leadership to the frontline adjusters understands their role in the escalation pathway.
How does looking beyond a single payer’s data through cross-payer collaboration provide a more comprehensive defense against sophisticated billing schemes?
Collaboration is the ultimate force multiplier because a single health plan, no matter how large, only sees its own slice of a provider’s behavior. When we work with partners who have a broader view across multiple plans and markets, we can identify systemic issues that would be invisible in a silo. A great example of this is seen in the Claim Pattern Review (CPR) process, where we might monitor a provider’s activity over a full 12-month period. In one instance, this wider lens revealed a provider with a 100% error rate, where nearly every single record reviewed failed to support the services they were billing. Because of this cross-payer visibility, we saw a 70% technical denial rate because the provider simply couldn’t produce the records to back up their claims, and even after appeals, there was an 85% uphold rate on those denials. By comparing these findings across other participating health plans, we were able to confirm that this wasn’t an isolated clerical error but a systemic pattern of outlier billing. This kind of partnership allows us to move faster and think more holistically, protecting the entire healthcare system rather than just one plan at a time.
What is your forecast for the future of payment integrity as we navigate the complexities of 2026 and beyond?
I believe we are moving toward a future where payment integrity is no longer a “back-office” function but a core component of the clinical value chain. From 2026 to 2028, we will see an even deeper integration of AI-driven behavioral biometrics and real-time clinical validation that happens at the moment of care, rather than weeks later. We will transition from simply identifying “improper payments” to a model of “assured accuracy,” where the friction between payers and providers is significantly reduced because the rules of engagement are transparent and enforced by data-driven governance. My advice for readers is to stop looking at FWA prevention as a series of isolated investigations and start treating it as a disciplined, interdisciplinary practice that balances technology with human expertise. The organizations that thrive will be those that foster a culture of shared accountability, where every stakeholder—from the actuary to the clinician—understands that preserving the financial health of the system is the only way to ensure the long-term physical health of the members.
